Exploring Social Determinants of Health in Uncomplicated UTIs

Panelists discuss how social determinants of health significantly influence uncomplicated urinary tract infection (UTI) prevalence and outcomes, with patients with lower income, those from rural areas, and those lacking consistent health care access experiencing higher infection rates, delayed treatment, increased complications, and poorer overall treatment success.

EP: 1.Differentiating Uncomplicated and Complicated Urinary Tract Infections (UTIs)

EP: 2.Trends in Uncomplicated UTIs

Now Viewing

EP: 3.Exploring Social Determinants of Health in Uncomplicated UTIs

Video content above is prompted by the following:

• How do social determinants such as socioeconomic status, access to health care, and geographic location affect the prevalence and treatment outcomes in patients with uncomplicated UTIs?

Related Videos

Related Content

Advertisement

March 15th 2025

FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis

Luke Halpern

The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the indication to include pediatric patients who are 6 years or older and positive for antiacetylcholine receptor antibodies.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

March 14th 2025

5 Ongoing Clinical Trials Evaluating Treatment for MS

Maggie L. Shaw

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by MS Focus: the Multiple Sclerosis Foundation and affiliated groups.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

March 13th 2025

Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy

Christina Mattina

The 2025 Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature clinical updates, expert insights, and breaking trial findings that sum up to a new frontier of care for neuromuscular diseases.

March 12th 2025

Frailty, Housing Instability Drive Mortality Risk in People With HIV

Brooke McCormick

These abstracts highlight the compounded challenges people with HIV face.

Related Content

Advertisement

March 15th 2025

FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis

Luke Halpern

The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the indication to include pediatric patients who are 6 years or older and positive for antiacetylcholine receptor antibodies.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

March 14th 2025

5 Ongoing Clinical Trials Evaluating Treatment for MS

Maggie L. Shaw

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by MS Focus: the Multiple Sclerosis Foundation and affiliated groups.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

March 13th 2025

Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy

Christina Mattina

The 2025 Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature clinical updates, expert insights, and breaking trial findings that sum up to a new frontier of care for neuromuscular diseases.

March 12th 2025

Frailty, Housing Instability Drive Mortality Risk in People With HIV

Brooke McCormick

These abstracts highlight the compounded challenges people with HIV face.